Actively Recruiting

Phase Not Applicable
All Genders
Healthy Volunteers
NCT06941753

Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge

Led by Peking Union Medical College Hospital · Updated on 2025-06-26

22

Participants Needed

1

Research Sites

114 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a single-center, randomized, open-label, controlled, endpoint-blinded study to assess the effect of off-script diagnosis \& differential diagnosis (D\&D) training in improving the residents' knowledge of acute ischemic stroke in China. The investigators will enroll 22 residents and assess the score of mASMaQ 30 days after randomization.

CONDITIONS

Official Title

Off-script Diagnosis & Differential Diagnosis (D&D) Training and Residents' Stroke Knowledge

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Residents (physicians in postgraduate training)
  • Currently working in neurology wards
  • Managing acute ischemic stroke patients with onset to randomization time ≤ 2 weeks or using last known well time if onset unknown
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Managing asymptomatic ischemic stroke patients
  • Participated in another interventional ischemic stroke training program within the past 3 months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China, 100730

Actively Recruiting

Loading map...

Research Team

S

Shengde Li, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here